首页> 外国专利> Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases

Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases

机译:包含罗氟司特和选自异丙托铵,奥托托铵和噻托铵盐的抗胆碱能药的协同组合,用于治疗呼吸系统疾病

摘要

The invention relates to the administration of roflumilast and an anticholinergic agent selected from the group of an ipratropium, oxitropium or tiotropium salt for the treatment of respiratory diseases.
机译:本发明涉及罗氟司特和选自异丙托溴铵,氧噻托铵或噻托铵盐的组的抗胆碱能药的治疗呼吸道疾病的给药。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号